General Science
Global

General Science Experts

Michael Martin


Observer of the Board
Univercells
Austria

Biography

Michal Martin brings to our board over ten years of experience in biotech, venture capital, pharma business development and R&D. Prior to TVI, Michael was a member of Global Licensing & BD Takeda, Vice President of Preclinical Development of Intellikine, and held several executive positions with TargeGen (acquired by Sanofi-Aventis), Arena Pharmaceuticals, and the Monsanto Corporation

Research Interest

pharma

Global Experts from Austria

Global Experts in Subject

Share This Profile